Huemer, Florian
Rinnerthaler, Gabriel
Jörg, Benedikt
Morre, Patrick
Stegbuchner, Birgit
Proksch, Elisabeth
Fleimisch, Stefanie
Oberkofler, Hannes
Kremser, Iris
Greil, Richard
Egle, Alexander
Article History
Received: 19 December 2020
Accepted: 8 March 2021
First Online: 10 April 2021
Declarations
:
: FH reports travel support from Roche. RG reports honoraria from Celgene, Roche, Merck, Takeda, AstraZeneca, Novartis, Amgen, BMS, MSD, Sandoz, Abbvie, Gilead, and Daiichi Sankyo; consulting for Celgene, Roche, Merck, Takeda, AstraZeneca, Novartis, BMS, MSD, Abbvie, Gilead, Daiichi Sankyo, and Janssen; research funding from Celgene, Roche, Merck, Takeda, AstraZeneca, Novartis, Amgen, BMS, MSD, Sandoz, Gilead, Daiichi Sankyo; travel support from Celgene, Roche, AstraZeneca, Novartis, Amgen, BMS, MSD, Abbvie, Gilead, and Janssen. AE reports consulting and honoraria from Roche. All other authors declare no competing interests.